Primary record
N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1 pound not2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2 pound not4-dimethyl-1H-pyrrole-3-carboxamide
- 库存
- 3,774 克
- 纯度
- 99.2 %
- CAS
- 557795-19-4
化合物标识与属性
- CAS
- 557795-19-4
- PubChem CID
- 5329102
- SMILES
- CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C
- Canonical SMILES
- CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C
名称与同义词
- Sunitinib
- Sutent
- Sunitinib malate
- sunitinibum
- 557795-19-4
- Sunitinib Base
- xamide
- Sunitanib
- Sunitinib base?
- Sunitinib (INN)
- Sunitinib [INN]
- Sunitinib-d4
- (Z)-Sunitinib
- Sunitinib, Free base
- SU11248
- SU-11248
- Sunitinib (free base)
- PDGF TK antagonist
- Sutent (free base)
- Sutent (TN)
- yrrole-3-carboxamide
- Sunitinib [INN:BAN]
- Sunitinib (Standard)
- Su-011248
- CHEMBL535
- RefChem:56080
- SUNITINIB [MI]
- SUNITINIB [VANDF]
- Sunitinib malate [USAN]
- MFCD09260778
- C22H27FN4O2
- D0R0MW
- UNII-LVX8N1UT73
- AC1NS62J
- SCHEMBL8081
- SUNITINIB [WHO-DD]
- DTXSID1041134
- SUNITINIB [EMA EPAR]
- UNII-V99T50803M
- cc-689
- CHEBI:38940
- HSDB 7932
- SU011248 L-malate salt
- NSC-750690
- Sunitinib (Pan-TK inhibitor)
- PHA-290940AD
- 342641-94-5
- BDBM4814
- GTPL5713
- orb1310675
- QCR-67
- Sutent, Sunitinib, SU11248
- DTXCID9021134
- NSC-736511
- SU 11248
- SU011248
- V99T50803M
- CHEBI:91430
- N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide
- EX-A553
- L01XE04
- NSC750690
- s7781
- WINHZLLDWRZWRT-ATVHPVEESA-N
- BCPP000057
- HMS5085H20
- HMS6018M17
- HY-10255AR
- K00588a
- AOB87111
- KS-5022
- Sunitinib base - Bio-X trade mark
- ZINC3964325
- C22-H27-F-N4-O2
- CF-876
- EBC-12065
- HY-10255A
- MFCD09743439
- NSC800937
- SU-11248J
- AKOS015908193
- AKOS025312424
- ACN-036767
- AN-9681
- CCG-268638
- CID5329102
- CS-1670
- CS-O-11750
- DB01268
- FD32120
- NSC 736511
- NSC 750690
- NSC-800937
- SDCCGSBI-0634415.P005
- NCGC00164631-01
- NCGC00164631-02
- NCGC00164631-04
- NCGC00164631-21
- AJ-47545
- BD164426
- EN002687
- N-[2-(diethylamino)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrole-3-carboxamide
- Q572
- SC-47294
- SU-12662
- SU010398
- SY013948
- AB0017673
- LS-187023
- LS-187648
- ST2413814
- SU 011248
- SU-010398
- 2035B
- AM20090630
- FT-0651493
- FT-0659515
- NS00004661
- C22-H27-F-N4-O2.C4-H6-O5
- J1.942.549E
- J2.036.576E
- 95S194
- D08552
- EN300-323230
- H38037
- J90060
- W-2596
- (Z)-N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide
- AB01273976-01
- AB01273976-02
- AB01273976_04
- N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
- A822143
- A830806
- Q417542
- SR-00000000005
- I01-1229
- n-(2-(diethylamino)ethyl)-5-((z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-2,4-dimethyl-1h-pyrrole-3-carboxamide
- SR-00000000005-2
- BRD-K42828737-001-03-3
- BRD-K42828737-044-09-0
- BRD-K42828737-044-10-8
- BRD-K42828737-044-12-4
- Q27163278
- 1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-
- 341031-54-7
- ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide
- Z2568722545
- B0084-186154
- N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-
- 341031-54-7 (malate); 557795-19-4 (free base).
- 5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE
- N-(2-(DIETHYLAMINO)ETHYL)-5-((Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE
- N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
- N-[2-(diethylamino)ethyl]-5-[(5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
- N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
- N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
- 1H-Pyrrole-3-carboxamide,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-
- (E)-N-[2-(Diethylamono)ethyl]-5-[(5-fluoro-2-oxo-1,2-dihydro-3H-indole-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
- (Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-p
- (Z)-N-[2-(Diethylamino)ethyl]-5-[(5-fluoro-2-oxo-3-indolinylidene)methyl]-2,4-dimethylpyrrole-3-carboxamide
- 111-194-2
- 1126641-10-8
- 1126721-79-6
- 1691223-83-2
- 1H-PYRROLE-3-CARBOXAMIDE,N-[2-(DIETHYLAMINO)ETHYL]-5-[(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL-(9CI)
- 1H-Pyrrole-3-carboxamide,N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-
- 5-(5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylamino-ethyl)-amide
- 5-(5-Fluoro-2-oxo-1,2-dihydroindol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid (2-diethylaminoethyl)amide
- 5-(5-fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide
- 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylamino-ethyl)-amide
- 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid(2-diethylamino-ethyl)-amide
- B49
- N-(2-(diethylamino)ethyl)-5-(((3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide
- N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1 pound not2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2 pound not4-dimethyl-1H-pyrrole-3-carboxamide
- N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide
- N-[2-(Diethylamino)ethyl]-2,4-dimethyl-5-(2-oxo-5-fluoroindoline-3-ylidenemethyl)-1H-pyrrole-3-carboxamide
- N-[2-(Diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-(2-oxo-5-fluoroindoline-3-ylidene)methyl]-1H-pyrrole-3-carboxamide
- N-[2-(Diethylamino)ethyl]-5-(2-oxo-5-fluoroindoline-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide
- N-[2-(diethylamino)ethyl]-5-[(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
- n-[2-(diethylamino)ethyl]-5-[(z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide
- N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indole-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
- N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carbo
- N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carbo xamide
- N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indole-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
- N-[2-(Diethylamino)ethyl]-5-[(Z)-[5-fluoro-2-oxo-1H-indole-3(2H)-ylidene]methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
- N-[5-(Trifluoromethyl)-2-pyridinyl]-trans-4-[[(1,1-dimethylethyl)sulfonyl]amino]cyclohexane-1-carboxamide